Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery
Brain · 23.06.2026
DOI: 10.1093/brain/awag216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 23.06.2026. Verfasst von Ting-Chen Wang und 36 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Memory and Alzheimer's Center, Vanderbilt Health, Nashville, TN, 37203, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Histopathological assessment has served as the gold standard for diagnosing Alzheimer’s disease (AD). Emerging technological advancements, including the development of amyloid positron emission tomography (PET), have enabled early detection of amyloid pathology, one of the neuropathological hallmarks of AD. Genome-wide association study (GWAS) across cohorts of aging and AD, leveraging different measurements of amyloid burden, may facilitate the identification of novel genetic variants that drive the earliest neuropathological changes in AD. This study presents the largest GWAS of brain amyloidosis to date, leveraging amyloid β (Aβ) measured by in vivo amyloid PET and postmortem histopathology from 13,555 individuals of European ancestry. Amyloid positivity was defined as moderate or frequent neuritic plaques according to the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) staging scores for each postmortem cohort. A Gaussian mixture model (GMM) was applied to each amyloid PET cohort to identify the cohort and tracer-specific cut-offs that differentiate amyloid positive and negative populations. In silico and ex vivo analyses further characterized implicated loci, including interrogating the association between bulk and single-nucleus gene expression profiles and AD-related traits. Genetic covariance analysis assessed the extent amyloid PET and postmortem measures reflect the shared genetic architecture of brain amyloidosis. Our combined amyloidosis GWAS identified three established AD risk loci: BIN1 (rs6733839, OR = 1.20, 95% CI 1.14-1.26, P = 1.32 × 10−11), CR1 (rs4844610, OR = 1.24, 95% CI = 1.16-1.32, P = 4.21 × 10−10), APOE (rs429358, OR = 4.01, 95% CI = 3.66-4.38, P = 4.54 × 10−201), and a newly identified brain amyloidosis-associated variant on chromosome 17 (rs35635959, OR = 1.18, 95% CI = 1.12-1.25, P = 1.47 × 10−8). SuSiE fine-mapping identified a single credible set of 15 putative causal variants with rs35635959 as the lead variant. Subsequent eQTL and SuSiE-based colocalization analyses prioritized rs35635959 as a strong eQTL for TUBG2, encoding tubulin gamma 2, which is involved in microtubule organization and synaptic plasticity. Further cell-type-specific characterization of this gene in neurons from dorsolateral prefrontal cortex tissue indicated that decreased TUBG2 expression was associated with increased Aβ burden and AD case status (PFDR < 0.045). Furthermore, our study is the first to report a modest genetic covariance (covariance=0.17, P < 6.54 × 10−8) between the genetic architecture of amyloid burden captured by different modalities. While APOE showed a strong association with both amyloid endophenotypes, the observed genetic covariance was not substantially attenuated after excluding variants within the APOE region (covariance=0.16, P < 1.32 × 10−7). Our results highlight the benefits of leveraging compatible, harmonized AD endophenotypes to increase power to uncover new molecular insights into the etiology of AD neuropathology. Wang et al. present the largest GWAS of brain amyloidosis to date, analysing 13,555 individuals using amyloid PET and postmortem Aβ measures. They identify a novel amyloidosis-associated variant on chromosome 17, demonstrate genetic covariance between modalities, and highlight complex traits sharing genetic architecture with Aβ burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt Health, Nashville, TN, 37203, USA.
- Vanderbilt Genetics Institute, Vanderbilt Health, Nashville, TN, 37232, USA.
- Department of Psychiatry, Washington University, St. Louis, MO, 63110, USA.
- NeuroGenomics and Informatics, Washington University, St. Louis, MO, 63108, USA.
- Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, 94305, USA.
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
ORCID-Profile: Ting-Chen Wang, Derek B Archer, Yiyang Wu, Rachel F Buckley, Philip L De Jager, David A Bennett, Lisa L Barnes, William S Bush, Prashanthi Vemuri, Vijay K Ramanan, Theresa M Harrison, William J Jagust, Simon M Laws, Jennifer E Below, Carlos Cruchaga, Timothy J Hohman, Logan Dumitrescu
Förderung
- NIA NIH HHS
Zitieren
APA
Wang, T. C., Archer, D. B., Ali, M., Wu, Y., Mormino, E., Buckley, R. F., Lee, A. J., Saykin, A. J., De Jager, P. L., Schneider, J. A., Bennett, D. A., Barnes, L. L., Vardarajan, B., Mayeux, R., Kunkle, B. W., Bush, W. S., Dirk Keene, C., Seshadri, S., Sperling, R. A., …, & Dumitrescu, L. (2026). Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery. Brain. https://doi.org/10.1093/brain/awag216
Vancouver
Wang TC, Archer DB, Ali M, Wu Y, Mormino E, Buckley RF, et al. Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery. Brain. 2026. doi:10.1093/brain/awag216
BibTeX
@article{Wang2026,
author = {Wang, Ting-Chen and Archer, Derek B and Ali, Muhammad and Wu, Yiyang and Mormino, Elizabeth and Buckley, Rachel F and Lee, Annie J and Saykin, Andrew J and De Jager, Philip L and Schneider, Julie A and Bennett, David A and Barnes, Lisa L and Vardarajan, Badri and Mayeux, Richard and Kunkle, Brian W and Bush, William S and Dirk Keene, C and Seshadri, Sudha and Sperling, Reisa A and Vemuri, Prashanthi and Ramanan, Vijay K and Ilyas Kamboh, M and Harrison, Theresa M and Jagust, William J and Laws, Simon M and Schellenberg, Gerard D and Huentelman, Matt and Hamilton-Nelson, Kara and Pericak-Vance, Margaret A and Goate, Alison M and Haines, Jonathan L and Montine, Thomas J and Beecham, Gary and Below, Jennifer E and Cruchaga, Carlos and Hohman, Timothy J and Dumitrescu, Logan},
title = {Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag216}
}
EUVIMED